Compare Stocks → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSE:FRXNASDAQ:IMVNASDAQ:RPHMTSE:RVXCVE:SNG Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFRXForest Road Acquisition$10.30$9.72▼$18.20$450MN/A2.07 million shs40,482 shsIMVIMV$0.66$0.48▼$12.70$9.63M0.95233,607 shs44,800 shsRPHMReneo Pharmaceuticals$1.67+1.2%$1.66$0.98▼$10.98$55.81M0.24271,055 shs115,223 shsRVXResverlogixC$0.06C$0.06C$0.05▼C$0.15C$16.33M0.7836,693 shs26,153 shsSNGSilver Range ResourcesC$0.10+11.8%C$0.08C$0.06▼C$0.15C$9.02M-0.0330,953 shs1,500 shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFRXForest Road Acquisition0.00%0.00%0.00%0.00%0.00%IMVIMV0.00%0.00%0.00%0.00%+6.80%RPHMReneo Pharmaceuticals-1.79%-6.25%0.00%0.00%-83.45%RVXResverlogix-8.33%0.00%0.00%-21.43%-59.26%SNGSilver Range Resources0.00%-5.00%+35.71%+35.71%-29.63%Move Your Money Before May 1 (Ad)Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationFRXForest Road AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AIMVIMVN/AN/AN/AN/AN/AN/AN/AN/ARPHMReneo Pharmaceuticals1.7405 of 5 stars2.90.00.00.03.22.51.3RVXResverlogixN/AN/AN/AN/AN/AN/AN/AN/ASNGSilver Range ResourcesN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFRXForest Road AcquisitionN/AN/AN/AN/AIMVIMV2.00HoldN/AN/ARPHMReneo Pharmaceuticals1.88Reduce$18.14986.08% UpsideRVXResverlogixN/AN/AN/AN/ASNGSilver Range ResourcesN/AN/AN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFRXForest Road AcquisitionN/AN/AN/AN/A$0.56 per shareN/AIMVIMV$330K0.00N/AN/A($0.69) per share0.00RPHMReneo PharmaceuticalsN/AN/AN/AN/A$2.66 per shareN/ARVXResverlogixN/AN/AC$0.00 per share132.50C($0.26) per shareN/ASNGSilver Range ResourcesN/AN/AC$0.01 per share16.25C$0.11 per shareN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFRXForest Road Acquisition-$7.92MN/A0.00N/AN/AN/AN/AN/AN/AIMVIMV-$37.99M-$4.59N/AN/AN/A-11,547.42%-12,695.41%-104.84%N/ARPHMReneo Pharmaceuticals-$77.39M-$2.52N/AN/AN/AN/A-73.14%-63.85%5/9/2024 (Estimated)RVXResverlogix-C$12.82M-C$0.05N/A∞N/AN/AN/A-37.10%5/9/2024 (Estimated)SNGSilver Range Resources-C$1.69M-C$0.02N/A∞N/AN/A-16.23%-9.12%5/2/2024 (Estimated)Latest FRX, SNG, RVX, IMV, and RPHM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/1/2024Q4 2023RVXResverlogixN/A-C$0.01-C$0.01-C$0.01N/AN/A3/28/2024Q4 2023RPHMReneo Pharmaceuticals-$0.55-$0.70-$0.15-$0.70N/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthFRXForest Road AcquisitionN/AN/AN/AN/AN/AIMVIMVN/AN/AN/AN/AN/ARPHMReneo PharmaceuticalsN/AN/AN/AN/AN/ARVXResverlogixN/AN/AN/AN/AN/ASNGSilver Range ResourcesN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioFRXForest Road AcquisitionN/A0.370.37IMVIMVN/A2.932.93RPHMReneo PharmaceuticalsN/A5.875.87RVXResverlogixN/A0.110.04SNGSilver Range Resources0.075.827.93OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFRXForest Road AcquisitionN/AIMVIMV15.37%RPHMReneo Pharmaceuticals90.98%RVXResverlogixN/ASNGSilver Range ResourcesN/AInsider OwnershipCompanyInsider OwnershipFRXForest Road AcquisitionN/AIMVIMV0.33%RPHMReneo Pharmaceuticals17.90%RVXResverlogix43.19%SNGSilver Range Resources38.33%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableFRXForest Road AcquisitionN/A37.50 millionN/ANot OptionableIMVIMV9711.71 million11.67 millionOptionableRPHMReneo Pharmaceuticals833.42 million27.44 millionOptionableRVXResverlogix19272.17 millionN/ANot OptionableSNGSilver Range ResourcesN/A94.97 millionN/ANot OptionableFRX, SNG, RVX, IMV, and RPHM HeadlinesSourceHeadlineWe'd forgotten quite how many Depeche Mode bargains Alan Wilder shifted in his legendary auctionmsn.com - April 26 at 9:44 AMThese are West Michigan's top 10 places to go birdingwzzm13.com - April 26 at 9:44 AMSilver Range Resources Ltd. to Present at Metals & Mining Virtual Investor Conference May 2ndfinance.yahoo.com - April 24 at 5:37 PMState Police Asking for Public’s Help Locating Suspect Vehicles in Fatal Pedestrian Hit-and-Run Crashtownsquaredelaware.com - April 23 at 4:34 PMGorgeous Anushka Sen Age, Height, Bio, Net Worth, Family, and More in 20240technosports.co.in - April 9 at 10:25 AMEndicott Business Owners Brace for Big Washington Avenue Projectwnbf.com - April 4 at 6:28 PMSilver Lake to Take Endeavor Privatetmcnet.com - April 2 at 3:22 PMOutdoors North: No lack of beautiful landscapes to visitminingjournal.net - March 29 at 4:43 PMBurlington Free Pressmsn.com - March 28 at 12:49 PMHow Quinta Brunson Hacked the Sitcomnewyorker.com - March 18 at 9:43 AMTwo Veteran Hikers Launch Seniq, an Outdoor Wear Line Catering to Womenmsn.com - March 14 at 7:20 PMOct. 7: Rape as an instrument of genocideclevelandjewishnews.com - March 13 at 3:00 PMReview: Ariana Grande isn’t perfect, and neither is ‘eternal sunshine’nyunews.com - March 13 at 9:59 AMThree Wyoming Authors Awarded Western Writing's Highest Honorcowboystatedaily.com - March 13 at 9:59 AMSkyfire, the Canberra Comedy Festival, and the Balloon Spectacular: 50+ things to do this weekhercanberra.com.au - March 11 at 8:29 PMWhat’s happening around New Mexico February 23-29msn.com - February 23 at 1:38 PMGame-changer for NJ beauty services: These are salon suites in New Jerseynj1015.com - February 21 at 4:33 PMTHIS UNIVERSITY OF FLORIDA PROGRAM OFFERS INSIGHTS INTO SUSTAINABLE LANDSCAPINGkeysweekly.com - February 21 at 4:33 PMTexas tough: Defense shines when offense struggles in virtual must-win over Kansas Statemsn.com - February 20 at 7:40 AMUMG Nashville Launches Silver Wings Records, Signs Huestonyahoo.com - February 15 at 6:02 PMDr. Jeremy Silver: Heart health risk factors to be aware ofwgnradio.com - February 4 at 2:52 PMMultiplayer Strategy Game “RoboHero” Featuring Seamless Integration of Tokens and NFTs to Launch on WEMIX PLAYmarkets.businessinsider.com - February 4 at 9:52 AMLocal Author's Book Available at Carson Tahoe Medical Center gift shopcarsonnow.org - February 4 at 9:52 AMCarson High School debate team shines at home tournamentcarsonnow.org - January 31 at 2:37 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsForest Road AcquisitionNYSE:FRXForest Road Acquisition Corp. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the technology, media, and telecommunications space. The company was founded in 2020 and is based in New York, New York.IMVNASDAQ:IMVIMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. Its immune-educating technology includes DPX which is designed to inform a specific, coordinated, and persistent anti-tumor immune response. The company was founded on May 18, 2007 and is headquartered in Dartmouth, Canada.Reneo PharmaceuticalsNASDAQ:RPHMReneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases. The company's lead product candidate is REN001, a potent and selective agonist of the peroxisome proliferator-activated receptor delta that is in clinical development for genetic mitochondrial diseases comprising primary mitochondrial myopathies and long-chain fatty acid oxidation disorders. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in Irvine, California.ResverlogixTSE:RVXResverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases. Resverlogix Corp. has a partnership with Eversana Life Science Services, LLC to support the pending launch of the commercialization of apabetalone for Covid-19 in the United States and Canada; and developing cardiovascular and pulmonary arterial hypertension indications. The company was founded in 2001 and is headquartered in Calgary, Canada.Silver Range ResourcesCVE:SNGSilver Range Resources Ltd., a junior resource exploration company, engages in the acquisition, exploration, and evaluation of precious metal resources in Canada. The company explores for gold, silver, zinc, lead, and copper deposits. Its property portfolio comprises mineral properties located in Nevada, the Northwest Territories, Nunavut, and the Yukon Territory. Silver Range Resources Ltd. was incorporated in 2010 and is headquartered in Vancouver, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.